Sure nations around the world consist of a "substantially similar" capture-all clause within their drug regulation, which include New Zealand and Australia. This contains 6-APB since it is comparable in chemical structure to The category A drug MDA, meaning six-APB can be considered as being a managed compound analogue in these jurisdictions.[19]�